Altogen Labs
Altogen Labs is a biotechnology company that conducts contract research and manufactures consumables for the biomedical sector.[1]
Company Operations[edit]
Altogen Labs was founded in 2009,[1] with an initial GLP-compliant facility.[2] The company specialized in xenograft models and their use in preclinical drug development,[1] focusing on the delivery of nucleic acids into rodents as part of gene therapy testing.[3][4]
Subsidiaries[edit]
The company has two subsidiaries; a Las Vegas, Nevada transfection-focused division, Altogen Biosystems, that manufactures cell line-specific reagents based on liposomes and polymers,[4][5] and a chemical subsidiary, Altogen Chemicals, which manufactures organic compounds and hexachlorodisilane.[6]
References[edit]
- ↑ 1.0 1.1 1.2 Miles, Jonathan (April 2017). "Medical Discovery and Innovation Preclinical Contract Research Services by Altogen Labs". GHP Magazine: 1–15.
- ↑ Lorek, Laura (31 January 2013). "11 Startups Join Texas Venture Lab's Spring 2013 Accelerator". Silicon Hills News. Retrieved 1 July 2018.
- ↑ Roberts, Josh P. (12 August 2014). "Primary Cells Pose No Problem with These Transfection Tools". Biocompare. Retrieved 1 July 2018.
- ↑ 4.0 4.1 Blow, Nathan (13 December 2007). "Small RNAs: Delivering the future". Nature. 450: 1117–1120. doi:10.1038/4501117a.
- ↑ "New Products". Science. 330 (6011): 1700. 17 December 2010. doi:10.1126/science.330.6011.1700-a.
- ↑ Ranjan, Vishal (3 June 2016). "Altogen Chemicals Launches Ultra-pure Hexachlorodisilane". Researz. Retrieved 1 July 2018.
External Links[edit]
This article "Altogen Labs" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Altogen Labs. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
